|Year : 2016 | Volume
| Issue : 1 | Page : 99-101
Reversible man-in-the-barrel syndrome in myasthenia gravis
Poornima A Shah1, Pettarusp Murzban Wadia2
1 Department of Clinical Neurophysiology, Jaslok Hospital and Research Centre, Mumbai, Maharashtra, India
2 Department of Neurology, Jaslok Hospital and Research Centre, Mumbai, Maharashtra, India
|Date of Submission||08-Jul-2015|
|Date of Decision||11-Aug-2015|
|Date of Acceptance||20-Sep-2015|
|Date of Web Publication||2-Feb-2016|
Poornima A Shah
Department of Clinical Neurophysiology, 2nd Floor, Jaslok Hospital and Research Centre, 15, Dr. G. Deshmukh Marg, Mumbai - 400 026, Maharashtra
Source of Support: None, Conflict of Interest: None
| Abstract|| |
Man-in-the-barrel syndrome (MBS) is an uncommon presentation due to bilateral, predominantly proximal muscle weakness that has not been described to be associated with myasthenia gravis. We describe a case of myasthenia gravis presenting as MBS. Additionally, he had significant wasting of the deltoids bilaterally with fibrillations on electromyography (EMG) at rest and brief duration (3-6 ms) bi/triphasic motor unit potentials (MUPs) on submaximal effort apart from a decremental response on repetitive nerve stimulation (RNS) at 2 Hz. While electrophysiology is an important tool in the diagnosis of myasthenia gravis, pathological EMG patterns do not exclude the diagnosis of myasthenia gravis.
Keywords: Electromyography (EMG), man-in-the-barrel syndrome (MBS), myasthenia gravis, reversible
|How to cite this article:|
Shah PA, Wadia PM. Reversible man-in-the-barrel syndrome in myasthenia gravis. Ann Indian Acad Neurol 2016;19:99-101
Man-in-the-barrel syndrome (MBS) refers to bilateral, predominantly proximal arm weakness. The etiology of MBS is varied, ranging in localization from central, spinal cord to peripheral including myopathic and neuropathic etiologies. ,, Herein we describe a patient who had MBS as a presenting symptom of myasthenia gravis among other atypical features.
A 77-year-old male presented on January 19, 2015 with history of mild left ptosis, intermittent diplopia, and difficulty in raising both arms since December 29, 2014. He had been operated on for bilateral cataracts on December 21 and 28, 2014 under local anesthesia. No neuromuscular blockade was used during the surgeries. The difficulty in raising both arms was fairly severe, symmetrical, and acute in onset. He denied radicular pain, numbness, paresthesiae, or fasciculations. He had no bulbar weakness or complaints in the lower limbs. Examination revealed bilateral fatiguable ptosis and normal extraocular movements. He had wasting of both bilateral shoulder girdle muscles with significant weakness of both deltoids (grade 2/5) [Video 1]. The hip girdle muscles also showed mild weakness (grade 4/5). There were no fasciculations. His gait, sensations, and deep tendon reflexes were normal and the plantars were flexor.
In this case, the key feature was MBS due to a peripheral cause [Table 1]. Given the ptosis and diplopia, myasthenia gravis was considered as a possibility, even though it has not been described to cause MBS. Brachial plexopathy or a bilateral C5-6 radiculopathy could present with MBS and wasting of the deltoids. However, there was no pain, reflexes were preserved with normal sensory examination, and the hip girdle weakness and ptosis could not be explained. The phenotype was atypical for a muscle disease. Because of the short duration of the symptoms it was difficult to explain the muscle atrophy. Involvement of ocular muscles is not seen in metabolic myopathies with short duration of symptoms.
The patient's antiacetylcholine receptor (anti-AChR) antibodies were elevated at 16.73 nMol/L (normal <0.25 nMol/L). Serum creatine phosphokinase (CPK) and thyroid hormones were in the normal range.
Electrophysiological studies showed normal peripheral motor and sensory conduction findings with normal compound muscle action potential amplitudes (CMAP) and decremental response to repetitive nerve stimulation (RNS) study at 2 Hz in the left deltoid (39%) and left orbicularis oculi (38%) [Figure 1]. Needle electromyography (EMG) in both deltoids revealed fibrillation and positive sharp waves at rest with brief duration (3-6 ms) bi/triphasic motor unit potentials (MUPs) on submaximal effort [Figure 2] and [Figure 3]. High-amplitude or long-duration potentials were not noted. On strong effort, a mild fallout was noted. Both tibialis anterior, left triceps, left first dorsal interosseus, right abductor digiti minimi, and tongue showed normal EMG findings. A diagnosis of myasthenia gravis was made on the basis of clinical findings, elevated anti-AChR antibodies, and decremental response to low-frequency RNS. He was treated with steroids, the dose increased gradually to reach 1 mg/kg per day. Within 20 days he had significant improvement with an improved range of shoulder movement (right more than left) and no signs or symptoms of extraocular muscle involvement.
|Figure 1: RNS of the axillary nerve, recording from left deltoid, nine stimuli at two per second showing resting and postexercise decremental response|
Click here to view
|Figure 2: Left deltoid spontaneous activity. Time base 100 ms, amplitude calibration 200 uv/div|
Click here to view
|Figure 3: Left deltoid volitional activity showing brief-duration low-amplitude MUPs. Time base 100 ms, amplitude calibration 200 uv/div|
Click here to view
| Discussion|| |
Predominant proximal arm weakness or MBS syndrome has been initially described with bilateral watershed cerebral infarction and has also been associated with brainstem and cord involvement. Peripheral nervous system involvement is usually insidious in onset and slowly progressive; it is most commonly associated with motor neuron disease. Myasthenia gravis has not been described to be associated with this rare clinical presentation. Apart from this presentation, the early-onset, severe atrophy of the shoulder girdle muscles, presence of fibrillation potentials, and positive sharp waves at rest and myopathic potentials on activation in the deltoid were unusual for myasthenia gravis. 
It is known that acetylcholine exerts a trophic influence on the muscle. Oosterhuis and Bethlem found muscular atrophy, confirmed histologically, in at least one of several groups of muscles in 14 out of 148 patients with generalized myasthenia gravis. As in this case, the proximal muscles were more involved. The mean duration of disease was 11 years compared to 6-8 years for patients without atrophy. No statistical correlation was found between the duration of disease and muscular atrophy, and atrophy was not the presenting symptom, contrary to our case. Six out of 14 patients showed EMG evidence of myopathy.  Neurogenic atrophy and pseudohypertrophy of the tongue have also been described in two cases of bulbar myasthenia where EMG showed evidence of neurogenic changes and the histology showed severe neurogenic atrophy with fatty pseudohypertrophy.  Axonal neuropathy and myositis as a cause of fibrillation potentials was ruled out by the normal nerve conduction study and the normal CPK levels. 
Muscular atrophy and atypical changes on EMG can occur in the setting of myasthenia gravis. This is the first account of a reversible MBS secondary to myasthenia gravis.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Sage JI, Van Uitert RL. Man-in-the-barrel syndrome. Neurology 1986;36:1102-3.
Orsini M, Catharino AM, Catharino FM, Mello MP, Freitas MR, Leite MA, et al.
Man-in-the-barrel syndrome, a symmetric proximal brachial amyotrophic diplegia related to motor neuron diseases: A survey of nine cases. Rev Assoc Med Bras 2009;55:712-5.
Antelo MJ, Facal TL, Sánchez TP, Facal MS, Nazabal ER. A case of cervical spinal cord infarction and review of the literature. Open Neurol J 2013;7:7-10.
Maher J, Grand'Maison F, Nicolle MW, Strong MJ, Bolton CF. Diagnostic difficulties in myasthenia gravis. Muscle Nerve 1998;21:577-83.
Oosterhuis H, Bethlem J. Neurogenic muscle involvement in myasthenia gravis. A clinical and histopathological study. J Neurol Neurosurg Psychiatry 1973;36:244-54.
Brownell B, Oppenheimer DR, Spalding JM. Neurogenic muscle atrophy in myasthenia gravis. J NeurolNeurosurg Psychiatry 1972;35:311-22.
[Figure 1], [Figure 2], [Figure 3]